Detalhe da pesquisa
1.
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.
N Engl J Med
; 385(13): 1172-1183, 2021 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34192426
2.
The Novavax Heterologous COVID Booster Demonstrates Lower Reactogenicity Than mRNA: A Targeted Review.
J Infect Dis
; 2023 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37992183
3.
Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
Clin Infect Dis
; 76(3): 398-407, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36210481
4.
Limiting Acute Kidney Injury Progression In Sepsis: Study Protocol and Trial Simulation.
Crit Care Med
; 49(10): 1706-1716, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33927121
5.
Clinical and economic impacts of large volume delayed sampling and pathogen reduction technology platelet processing strategies in the United States.
Transfusion
; 61(10): 2885-2897, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289101
6.
Mild traumatic brain injury in the United States: demographics, brain imaging procedures, health-care utilization and costs.
Brain Inj
; 33(9): 1151-1157, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31241427
7.
Oral GS-5806 activity in a respiratory syncytial virus challenge study.
N Engl J Med
; 371(8): 711-22, 2014 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25140957
8.
Burden and Impact of Reactogenicity among Adults Receiving COVID-19 Vaccines in the United States and Canada: Results from a Prospective Observational Study.
Vaccines (Basel)
; 12(1)2024 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38250896
9.
Safety and immunogenicity of the NVX-CoV2373 vaccine as a booster in adults previously vaccinated with the BBIBP-CorV vaccine.
Vaccine
; 42(7): 1777-1784, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38365482
10.
Factors associated with in-office influenza vaccination by U.S. pediatric providers.
BMC Pediatr
; 13: 180, 2013 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24195493
11.
Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines.
Expert Rev Vaccines
; 22(1): 620-628, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386785
12.
NVX-CoV2373 vaccine efficacy against hospitalization: A post hoc analysis of the PREVENT-19 phase 3, randomized, placebo-controlled trial.
Vaccine
; 41(22): 3461-3466, 2023 05 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37127523
13.
Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine.
Expert Rev Vaccines
; 22(1): 501-517, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246757
14.
Clinical guidance on the use of live attenuated influenza vaccine after inadvertent freezing and warming.
J Pediatr Nurs
; 27(2): 163-7, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22341195
15.
Elementary school-located influenza vaccine programs: key stakeholder experiences from initiation to continuation.
J Sch Nurs
; 28(4): 256-67, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22427316
16.
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial.
Lancet Respir Med
; 10(2): 167-179, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34800364
17.
Influenza vaccination of parents and guardians by US pediatricians.
Hum Vaccin
; 7(4): 436-40, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21445003
18.
Midturbinate Swabs Are Comparable to Nasopharyngeal Swabs for Quantitative Detection of Respiratory Syncytial Virus in Infants.
J Pediatric Infect Dis Soc
; 8(6): 554-558, 2019 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30462262
19.
Economic and clinical benefits of early identification of acute kidney injury using a urinary biomarker.
J Med Econ
; 22(12): 1281-1289, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31234668
20.
Development of a novel observer-reported outcome measure for the assessment of Respiratory Syncytial Virus (RSV) infection symptoms in pediatric clinical trials.
J Patient Rep Outcomes
; 2(1): 9, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29757334